Kistler-Tiffany Companies’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,019
| Closed | -$399K | – | 608 |
|
|
2019
Q3 | $399K | Sell |
4,019
-3,223
| -45% | -$306K | 0.15% | 86 |
|
|
2019
Q2 | $669K | Sell |
7,242
-1,746
| -19% | -$166K | 0.25% | 60 |
|
|
2019
Q1 | $848K | Sell |
8,988
-150
| -2% | -$13.1K | 0.35% | 48 |
|
|
2018
Q4 | $586K | Buy |
9,138
+686
| +8% | +$50.6K | 0.27% | 59 |
|
|
2018
Q3 | $756K | Buy |
8,452
+195
| +2% | +$17.2K | 0.31% | 55 |
|
|
2018
Q2 | $656K | Sell |
8,257
-84
| -1% | -$6.97K | 0.29% | 62 |
|
|
2018
Q1 | $744K | Buy |
8,341
+700
| +9% | +$67.2K | 0.31% | 59 |
|
|
2017
Q4 | $797K | Buy |
7,641
+937
| +14% | +$106K | 0.31% | 60 |
|
|
2017
Q3 | $978K | Hold |
6,704
| – | – | 0.41% | 46 |
|
|
2017
Q2 | $871K | Buy |
6,704
+125
| +2% | +$15.3K | 0.4% | 45 |
|
|
2017
Q1 | $819K | Buy |
6,579
+260
| +4% | +$31.1K | 0.39% | 47 |
|
|
2016
Q4 | $731K | Sell |
6,319
-145
| -2% | -$16.1K | 0.36% | 51 |
|
|
2016
Q3 | $676K | Buy |
6,464
+444
| +7% | +$48.1K | 0.33% | 53 |
|
|
2016
Q2 | $594K | Buy |
6,020
+255
| +4% | +$26.4K | 0.3% | 55 |
|
|
2016
Q1 | $577K | Buy |
5,765
+70
| +1% | +$7.21K | 0.32% | 55 |
|
|
2015
Q4 | $682K | Buy |
5,695
+500
| +10% | +$57.8K | 0.38% | 49 |
|
|
2015
Q3 | $562K | Sell |
5,195
-10
| -0.2% | -$1.24K | 0.34% | 54 |
|
|
2015
Q2 | $602K | Buy |
5,205
+350
| +7% | +$40K | 0.36% | 51 |
|
|
2015
Q1 | $560K | Buy |
4,855
+565
| +13% | +$67.5K | 0.36% | 53 |
|
|
2014
Q4 | $480K | Sell |
4,290
-756
| -15% | -$79.7K | 0.31% | 58 |
|
|
2014
Q3 | $478K | Buy |
5,046
+1,756
| +53% | +$158K | 0.32% | 58 |
|
|
2014
Q2 | $283K | Buy |
3,290
+2,140
| +186% | +$163K | 0.21% | 81 |
|
|
2014
Q1 | $80K | Buy |
1,150
+70
| +6% | +$5.54K | 0.06% | 181 |
|
|
2013
Q4 | $91K | Sell |
1,080
-100
| -8% | -$7.91K | 0.07% | 174 |
|
|
2013
Q3 | $91K | Hold |
1,180
| – | – | 0.07% | 167 |
|
|
2013
Q2 | $69K | Buy |
+1,180
| New | +$71K | 0.06% | 181 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Kistler-Tiffany Companies's CELG Position: Q4 2019 in Review
Kistler-Tiffany Companies sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,019 shares — an estimated $399K sold.
Kistler-Tiffany Companies first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $978K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Kistler-Tiffany Companies reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Kistler-Tiffany Companies sold 4,019 Celgene Corp shares in Q4 2019, an estimated $399K.
- Kistler-Tiffany Companies first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Kistler-Tiffany Companies's Celgene Corp position peaked at $978K in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Kistler-Tiffany Companies's 13F filing for Q4 2019, filed 14 Jan 2020.